Transgenic approach to the study of body weight regulation

Pharmacological Reviews

Volumn 52, Issue 1, 2000, Pages 35-61

  Inui, Akio ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GALANIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANOCORTIN; NEUROPEPTIDE Y; OPIATE PEPTIDE; OREXIN; SEROTONIN; UROCORTIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY WEIGHT; BROWN ADIPOSE TISSUE; ENERGY EXPENDITURE; FOOD INTAKE; GENE TARGETING; LIPOLYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; THERMOGENESIS; TRANSGENIC ANIMAL; WHITE ADIPOSE TISSUE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BODY WEIGHT; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMUS; LEPTIN; MICE; MICE, TRANSGENIC; OBESITY;

EID: 0034048279     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (410)

1. Adan RAH and Gispen WH (1997) Brain melanocortin receptors: From cloning to function. Peptides 18:1279-1287.
2. Akabayashi A, Koenig JI, Watanabe Y, Alexander JT and Leibowitz SF (1994) Galanin-containing neurons in the paraventricular nucleus: A neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci USA 91:10375-10379.
3. Alexander MJ, Miller MA, Dorsa DM, Bullock BP, Melloni RH Jr, Dobner PR and Leeman SE (1989) Distribution of neurotensin/neuromedin mRNA in rat forebrain: Unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci USA 86: 5202-5206.
4. Alleva E, Cirulli F, Bianchi M, Bondiolotti GP, Chiarotti F, De Acetis L and Panerai AE (1998) Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters. Eur J Neurosci 10:3664-3672.
5. Anand BK and Brobeck JR (1951) Hypothalamic control of food intake in rats and cats. Yale J Biol Med 24:123-140.
6. Asada H, Kawamura Y, Maruyama K, Kume H, Ding R-G, Kanbara N, Kuzume H, Sanbo M, Yagi T and Obata K (1997) Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94:8496-6499.
7. Asakawa A, Inui A, Ueno N, Makino S, Fujino MA and Kasuga M (1999) Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116:1287-1292.
8. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau J-P, Bortoluzzi M-N, Moizo L, Lehy T, Guerre-Millo M, Marchand-Brustel YL and Lewin MJM (1998) The stomach is a source of leptin. Nature 394:790-793.
9. Baik J-H, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M and Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428.
10. Baile CA and Della-Fera MA (1985) Central nervous system cholecystokinin and the control of feeding. Ann NT Acad Sci 448:424-430.
11. Baile CA, McLaughlin CL and Della-Fera MA (1986) Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev 66:172-234.
12. Balasubramaniam A (1997) Neuropeptide Y family of hormones: Receptor subtypes and antagonists. Peptides 18:445-457.
13. Baldo A, Sneiderman AD, St-Luce S, Kohen-Avramoglu R, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, and Cianflone K (1993) The adipsin/acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92:1543-1557.
14. Banks WA, Kastin AJ, Huang W, Jaspan JB and Maness LM (1996) Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311.
15. Barrachina MD, Martinez V, Wang L, Wei JY and Taché Y (1997) Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice Proc Natl Acad Sci USA 94:10455-10460.
16. Baskin DG, Breininger JF and Schwartz MW (1999) Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828-833.
17. Battey JF, Way JM, Corjay MH, Shapira H, Kusano K, Harkins R, Wu JM, Slattery T, Mann E and Feldman RI (1991) Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci USA 88:395-399.
18. Beattie JH, Wood AM, Newman AM, Bremner I, Choo KHA, Michalska AE, Duncan JS and Trayhurn P (1998) Obesity and hyperleptinemia in metallothionein (-| and -||) null mice. Proc Natl Acad Sci USA 95:358-363.
19. Beck B, Burlet A, Nicolas JP and Burlet C (1989) Neurotensin in microdissected brain nuclei and in the pituitary of the lean and obese Zucker rats. Neuropeptides 13:1-7.
20. Beck B, Burlet A, Nicolas JP and Burlet C (1993) Galanin in the hypothalamus of fed and fasted lean and obese Zucker rats. Brain Res 623:124-130.
21. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H and Lesch K-P (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
22. Bergen HT and Mobbs CV (1996) Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by fasting. Brain Res 707:266-271.
23. Bernardis LL and Bellinger LL (1996) The lateral hypothalamic area revisited: Ingestive behavior. Neurosci Biobehav Rev 20:189-287.
24. Berntson GG, Zipf WB, O'dorisio TM, Hoffman JA and Chance RE (1993) Pancreatic polypeptide infusions reduce food intake in Prader-Will syndrome. Peptides 14: 497-503.
25. Bessesen D and Faggioni R (1998) Recently identified peptides involved in the regulation of body weight. Semin Oncol 25:28-32.
26. Billington CJ, Levine AS and Morley JE (1983) Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. Am J Physiol 245:R920-R926.
27. Billington CJ, Briggs JE, Harker S, Grace M and Levine AS (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: A center coordinating energy metabolism. Am J Physiol 266:R1765-R1770.
28. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE and Flier JS (1998) Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625.
29. Blasquez C, Jegou S, Feuilloley M, Rosier A, Vandesande F and Vaudry H (1994) Visualization of gamma-aminobutyric acid A receptors on proopiomelanocortin-producing neurons in the rat hypothalamus. Endocrinology 135:2759-2764.
30. Blomqvist AG and Herzog H (1997) Y-receptor subtypes -how many more? Trends Neurosci 20:294-298.
31. Blundell JE, Lawton CL and Halford JC (1995) Serotonin, eating behavior, and fat intake. Obes Res 3:471S-476S.
32. Boston BA, Blaydon KM, Varnerin J and Cone RD (1997) Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278:1641-1644.
33. Bray GA (1993) The nutrient balance hypothesis: Peptides, sympathetic activity, and food intake. Ann NY Acad Sci 676:223-241.
34. Bray GA and York DA (1979) Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis. Physiol Rev 59:719-809.
35. Bray GA and York DA (1998) The MONA LISA Hypothesis in the time of leptin. Recent Prog Horm Res 53:95-118.
36. 2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66:393-408.
37. Broberger C, De Lecea L, Sutcliffe JG and Hökfelt T (1998a) Hypocretin/orexin-and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402:460-474.
38. Broberger C, Johansen J, Johansson C, Schalling M and Hökfelt T (1998b) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048.
39. Brüning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ and Kahn CR (1998) A muscle specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569.
40. Brunner D and Hen R (1997) Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann NY Acad Sci 836:81-105.
41. Bultman SJ, Michaud EJ and Woychik RP (1992) Molecular characterization of the mouse agouti locus. Cell 71:1195-1204.
42. Burrows HL, Nakajima M, Lesh JS, Goosens KA, Samuelson LC, Inui A, Camper SA and Seasholtz AF (1998) Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. J Clin Invest 101: 1439-1447.
43. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK and Lonsidine RV (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348:159-161.
44. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP and De Souza EB (1996) Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172.
45. Cheung CC, Clifton DK and Steiner RA (1997) Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492.
46. Chua S Jr and Leibel RL (1997) Obesity genes: Molecular and metabolic mechanisms. Diab Rev 5:2-7.
47. Civelli O, Bunzow JR and Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33:281-307.
48. Cole JL, Leventhal L, Pasternak GW, Bowen WD and Bodnar RJ (1995) Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res 678:168-176.
49. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA and Surwit RS (1996) Role of leptin in fat regulation. Nature 380:677.
50. Condie BG, Bain G, Gottlieb DI and Capecchi MR (1997) Cleft palate in mice with a targeted mutation in the γ-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc Natl Acad Sci USA 94:11451-11455.
51. Corwin RL, Robinson JK and Crawley JN (1993) Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 5:1528-1533.
52. Corwin RL, Rowe PM and Crawley JN (1995) Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol 269:R511-R518.
53. Costet P, Legendre C, More J, Edgar A, Galtier P and Pineau T (1998) Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273:29577-29585.
54. 1B serotonin receptors. Nat Genet 14:98-101.
55. Crawley J and Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731-755.
56. 5 receptor. J Clin Invest 102:2136-2145.
57. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL and McKnight GS (1996) Genetically lean mice result from targeted disruption of the R11 β subunit of protein kinase A. Nature 382:622-626.
58. Curzon G, Gibson EL and Oluyomi AO (1997) Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 18:21-25.
59. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, von den Pol AN, Bloom FE, Gautvik KM and Sutcliff JG (1998) The hypocretins: Hypothalamic-specific peptide with neuroexicitatory activity. Proc Natl Acad Sci USA 95:322-327.
60. Diano S, Naftolin F, Goglia F and Horvath TL (1998) Segregation of the intra-and extrahypothalamic neuropeptide Y and catecholaminergic inputs on paraventricular neurons, including those producing thyrotropin-releasing hormone. Regul Pept 75:/76: 117-126.
61. Dong ZM, Gutierrez-Ramos J-C, Coxon A, Mayadas TN and Wagner DD (1997) A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci USA 94:7526-7530.
62. Dourish CT, Rycroft W and Iversen SD (1989) Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245:1509-1511.
63. Drago J, Gerfen CR, Lachowicz JH, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ Huang SP, Barlett PF, Jose PA, Sibley DR and Westphal H (1994) Altered striatal function in a mutant mouse lacking D1a dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568.
64. Drucker DJ (1998) Glucagon-like peptides. Diabetes 47:159-169.
65. Dryden S, Pickavance L, Frankish HM and Williams G (1995) Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 690:185-188.
66. Dube MG, Horvath TL, Leranth C, Kalra PS and Kalra SP (1994) Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav 56:811-813.
67. Dube MG, Xu B, Kalra PS, Sninsky CA and Kalra SP (1999) Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res 816:38-46.
68. Dube MG, Kalra PS, Crowley WR and Kalra SP (1995) Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 690:275-278.
69. Donahey JC, Van Dijk G, Woods SC and Seeley RJ (1998) Intraventricular GLP-1 reduces short but not long-term food intake or body weight in lean and obese rats. Brain Res 779:75-83.
70. Edwards CMB, Abusnana S, Sunter D, Murphy KG, Ghatei MA and Bloom SR (1999) The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160:R7-R12.
71. Egawa M, Yoshimatsu H and Bray G (1991) Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol 260:R328-R334.
72. Egawa M, Yoshimatsu H and Bray GA (1993) Effect of β-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am J Physiol 264:R109-R115.
73. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan C-C, Ramachandran C, Gresser MJ, Tremblay ML and Kennedy BP (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphate-1B gene. Science 283:1544-1548.
74. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tarto JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M and Elmquist JK (1998) Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402:442-459.
75. Elmquist JK, Maratos-Flier E, Saper CB and Flier JS (1998) Unraveling the CNS pathway underlying responses to leptin. Nat Neurosci 1:445-450.
76. Elmquist JK, Elias CF and Saper CB (1999) From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22:221-232.
77. Enerbäck S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper M-E and Kozak LP (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387:90-94.
78. Erickson JC, Clegg KE and Palmiter RD (1996a) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-418.
79. Erickson JC, Hollopeter G and Palmiter RD (1996b) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707.
80. Erlanson-Albertsson C and York D (1997) Enterostatin - A peptide regulating fat intake. Obes Res 5:360-372.
81. Fan W, Boston BA, Kesterson RA, Hruby VJ and Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168.
82. Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA and Battey JF (1993) BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem 268:5979-5984.
83. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillard F, Seldin MF, Surwit RS, Ricquier D and Warden CH (1997) Uncoupling protein 2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet 16:269-272.
84. Flier JS (1998) What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83:1407-1413.
85. Flier JS and Maratos-Flier E (1998) Obesity and the hypothalamus: Novel peptides for new pathways. Cell 92:437-440.
86. Flynn FW (1992) Candal brain stem systems mediate effects of bombesin-like peptides on intake in rats. Am J Physiol 262:R39-R45.
87. Flynn FW (1993) Fourth ventricular injection of selective bombesin receptor antagonists facilitate feeding in rats. Am J Physiol 264:R218-R221.
88. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB and Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314.
89. Friedman JM (1998) Leptin, leptin receptors, and the control of body weight. Nut Rev 56:S38-S46.
90. Friedman JM and Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763-770.
91. Gayle D, Ilyin SE and Plata-Salaman CR (1997) Central nervous system IL-1β system and neuropeptide Y mRNAs during IL-1β-induced anorexia in rats. Brain Res Bull 44:311-317.
92. Gehlert DR (1998) Multiple receptors for the pancreatic polypeptide (PP-fold) family: Physiological implications. Proc Soc Exp Biol Med 218:7-22.
93. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA and Weinshank RL (1996) A receptor subtype involved in neuropeptide Y-induced food intake. Nature 382:168-171.
94. Gibbs J (1985) Effect of bombesin on feeding behavior. Life Sci 37:147-153.
95. Gibbs J and Smith GP (1992) Effects of brain-gut peptides on satiety, in Obesity (Björntorp P and Brodoff BN eds) pp 399-410, Lippincott, Philadelphia.
96. Gold RM (1973) Hypothalamic obesity: The myth of the ventromedial nucleus. Science 182:488-490.
97. Goldstone AP, Mercer JG, Gunn I, Moar KM, Edwards CM, Rossi M, Howard JK, Rasheed S, Turton MD, Small C, Heath MM, O'Shea D, Steere J, Meeran K, Ghatei MA, Hoggard N and Bloom SR (1997) Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 415:134-138.
98. Gong DW, He Y, Karas M and Reitman M (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta 3-adrenergic agonists, and leptin. J Biol Chem 272:24129-24132.
99. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H and Kirsch IR (1997) Hypogonadism and obesity in mice with a targeted mutation of the Nhlh2 gene. Nat Genet 15:397-401.
100. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W and Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
101. Graham M, Shutter JR, Sarmiento U, Sarosi I and Stark KL (1997) Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 17:273-274.
102. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J and Feingold KR (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97:2152-2157.
103. Gunn TM, Miller KA, He L, Hyman RW, Davis HW, Azarani A, Schlossman SF, Duke-Cohan JS and Barsh GS (1999) The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398:152-156.
104. Gutzwiller J-P, Drewe J, Hildebrand P, Rossi L, Lauper JZ and Beglinger C (1994) Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology 106:1168-1173.
105. Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest CA, Kozak CA, Boozer CN, Peng B, McEvoy RC, Good P, Kelley KA, Takahashi JS, Pintar JE, Roberts JL, Moobs CV and Salton SRJ (1999) Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23:537-548.
106. Hahn TM, Breininger JF, Baskin DG and Schwartz MW (1998) Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272.
107. Hampton LL, Ladenheim EE, Akeson M, Way JM, Weber HC, Sutliff VE, Jensen RT, Wine LJ, Arnheiter H and Battey JF (1998) Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. Proc Natl Acad Sci USA 95:3188-3192.
108. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM (1995) Weight reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546.
109. Hammer R, Brinster R, Rosenfeld M, Evans R and Mayo K (1985) Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-416.
110. Harrold JA, Widdowson PS and Williams G (1999) Altered energy balance causes selective changes in melanocortin-4 (MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: Further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48:267-271.
111. Haskell-Luevano C, Chen P, Li C, Chang K, Smith MS, Cameron JL and Cone RD (1999) Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology 140: 1408-1415.
112. Heinrichs SC, Cole BJ, Pich EM, Menzaghi F, Koob GF and Hauger RL (1991) Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor. Peptides 13:879-884.
113. Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW and De Souza EB (1996) Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 93:15475-15480.
114. Heinrichs SC, Menzaghi F and Koob GF (1998) Neuropeptide Y-induced feeding and its control. Vitam Horm 54:51-66.
115. Heisler LK, Kanarek RB and Gerstein A (1997) Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol Biochem Behav 58:767-773.
116. Hetherington AW and Ranson SW (1940) Hypothalamic legions and adiposity in rat. Anat Rec 78:149-172.
117. Himms-Hagen J (1992) Brown adipose tissue metabolism, in Obesity (Björntorp P and Brodoff BN eds) pp 15-34, Lippincott, Philadelphia.
118. Hirosue Y, Inui A, Teranishi A, Miura M, Nakajima M, Okita M, Nakajima Y, Himori N, Baba S and Kasuga M (1993) Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am J Physiol 265:R481-R486.
119. Hirsch E, Irikura VM, Paul SM and Hirsch D (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008-11013.
120. Hoebel BG, Rada P, Mark GP and Hernandez L (1994) The power of integrative peptides to reinforce behavior by releasing dopamine. Ann NY Acad Sci 739:36-41.
121. Hoebel BG, Rada P, Mark GP, Parada M, De Parada MP, Pothos E and Hernandez L (1996) Hypothalamic control of accumbens dopamine: A system for feeding reinforcement, in Molecular and Genetic Aspects of Obesity (Bray GA and Ryan DH ed) pp 263-280, Louisiana State University, Baton Rouge.
122. Hollopeter G, Erickson JC and Palmiter RD (1998a) Role of neuropeptide Y in diet-, chemical-and genetic-induced obesity of mice, Int J Obes Relat Metab Disord 22:506-512.
123. Hollopeter G, Erickson JC, Seeley RJ, Marsh DJ and Palmiter RD (1998b) Response of neuropeptide Y-deficient mice to feeding effectors. Regul Pept 75/76:383-389.
124. 3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 94:4143-4148.
125. Honda T, Wada E, Battey JF and Wank SA (1993) Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol Cell Neurosci 4:143-154.
126. Hopkins SJ and Rothwell NJ (1995) Cytokines and the nervus system 1: Expression and recognition. Trends Neurosci 18:83-88.
127. Horvath TL, Naftolin F, Leranth C, Sahu A and Kalra SP (1996) Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 137:3069-3078.
128. Horvath TL, Bechmann I, Naftolin F, Kalra SP and Leranth C (1997) Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756:283-286.
129. Horvath TL, Diano S and van den Pol AN (1999) Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in the metabolic and endocrine regulations. J Neurosci 19:1072-1087.
130. Hoyer D, Clarke DE, Fozard JD, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR and Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
131. Hulsey MG, Pless CM and Martin RJ (1995) Icv administration of anti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight. Regul Pept 59:241-246.
132. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P and Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
133. Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R and Abumrad NA (1999) Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274:26761-26766.
134. Ikeda A, Chang K-T, Matsumoto Y, Furuhata Y, Nishihara M, Sasaki F and Takahashi M (1998) Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 139:3057-3063.
135. Ingram SM, Krause RG, Baldino F Jr, Skeen LC and Lewis ME (1989) Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J Comp Neurol 287:260-272.
136. Inui A, Inoue T, Sakatani N, Oya M, Morioka H and Baba S (1987) Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog. Brain Res 417:355-359.
137. Inui A, Okita M, Inoue T, Sakatani N, Oya M, Morioka H, Oimomi M and Baba S (1989) Effect of cholecystokinin octapeptide analogues on food intake in the dog. Am J Physiol 257:R746-R751.
138. Inui A, Okita M, Nakajima M, Inoue T, Sakatani N, Oya M, Morioka H, Okimura Y, Chihara K and Baba S (1991) Neuropeptide regulation of feeding in dogs. Am J Physiol 261:R588-R594.
139. Inui A, Okita M, Nakajima M, Momose K, Ueno N, Teranishi A, Miura M, Hirosue Y, Sano K, Sato M, Watanabe M, Sakai T, Watanabe T, Ishida K, Silver J, Baba S and Kasuga M (1998) Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc Assoc Am Physicians 110:171-182.
140. Inui A (1999a) Feeding and body weight regulation by hypothalamic neuropeptides -Mediation of the actions of leptin. Trends Neurosci 22:62-67.
141. Inui A (1999b) Neuropeptide Y feeding receptors - Are multiple subtypes involved? Trends Pharmacol Sci 20:43-46.
142. Inui A (1999c) Neuropeptide Y: A key molecule in anorexia and cachexia in wasting disorders? Mol Med Today 5:79-85.
143. Inui A (1999d) Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 59:4493-4501.
144. Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M and Fukuroda T (1998) A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol 274:R1500-R1504.
145. 3-adrenergic receptors under the control of human gene regulatory elements. Diabetes 47:1464-1471.
146. Jacobson L (1999) Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice. Endocrinology 140:310-317.
147. Jain MR, Dube MG, Kalra SP and Kalra PS (1998) Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats. Neurosci Lett 256:21-24.
148. Jensen DR, Schlaepfer IR, Morin CL, Pennington DS, Marcell T, Ammon SM, Gutierrez-Hartmann, A and Eckel RH (1997) Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 273:R683-R689.
149. Kalra PS, Dube MG, Xu B and Kalra SP (1997) Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regul Pept 72:121-130.
150. 1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance. J Neuroendocrinol 10:43-49.
151. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL and Kalra PS (1999a) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100.
152. Kalra PS, Edwards TG and Dube MG (1999b) Hypothalamic galanin is upregulated during hyperphagia. Ann NY Acad Sci 863:432-434.
153. Kalra SP (1997) Appetite and body weight regulation: Is it all in the brain? Neuron 19:227-230.
154. 1 receptor antagonist, 1229U91: Blockade of neuropeptide Y-induced and physiological food intake. Endocrinology 137:3177-3182.
155. 1-like receptor in rodents. Regul Pept 75/76:409-415.
156. 5 receptor deficient mice. Abstracts of the 5th International NPY Meeting, Grand Cayman, p 31.
157. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D and Baekkeskov S (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94:14060-14065.
158. Kash SF, Tecott LH, Hodge C and Baekkeskov S (1999) Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 96:1698-1703.
159. Kask A, Rägo L, Mutulis F, Pahkla R, Wikberg JE and Schioth HB (1998a) Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Commun 245:90-93.
160. Kask A, Rägo L, Korrovits P, Wikberg JE and Schioth HB (1998b) Evidence that orexigenic effects of melanocortin 4 receptor antagonists HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 248:245-249.
161. Katz EB, Stenbit AE, Hatton K, Depinho R and Charron MJ (1995) Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377:151-155.
162. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B and Wahli W (1999) Peroxisome proliferator-activated receptor a mediates the adaptive response to fasting. J Clin Invest 103:1489-1498.
163. Kesterson RA, Huszar D, Lynch CA, Simerly RB and Cone RD (1997) Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11:630-637.
164. Kieffer BL (1999) Opioids: First lessons from knockout mice. Trends Pharmacol Sci 20:19-26.
165. King PJ and Williams G (1998) Role of ARC NPY neurons in energy homeostasis. Drugs News Perspect 11:402-410.
166. Klaus S, Münzberg H, Trüloff C and Heldmaier G (1998) Physiology of transgenic mice with brown fat ablation: Obesity is due to lowered body temperature. Am J Physiol 274:R287-R293.
167. Klebig ML, Wilkinson JE, Geisler JG and Woychik RP (1995) Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type diabetes, and yellow fur. Proc Natl Acad Sci USA 92:4728-4732.
168. Kopecky J, Clarke G, Enerbäck S, Spiegelman B and Kozak LP (1995) Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96:2914-2923.
169. 2-Ucp transgenic mice: physiology and adipose tissue distribution. Am J Physiol 270:E768-E775.
170. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H and Köhler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
171. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F,
172. Kozak LP, Kozak UC and Clarke GT (1991) Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev 5:2256-2264.
173. Kozak W, Poli V, Soszynski D, Conn CA, Leon LR and Kluger MJ (1997) Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol 272:R621-R630.
174. Krahn DD, Gosnell BA, Grace M and Levine AS (1986) CRF antagonist partially reverses CRF-and stress-induced effects on feeding. Brain Res Bull 17:285-289.
175. Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR and Bloom SR (1989) Characterization of glucagon-like peptide-1-(7-36) amide in the hypothalamus. Brain Res 502:325-331.
176. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ and Hastrup S (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76.
177. Kuhar MJ and Dall Vechia SE (1999) CART peptides: Novel addiction-and feeding-related neuropeptides. Trends Neurosci 22:316-320.
178. Kühn R, Schwenk F, Aguet M and Rajewsky K (1995) Inducible gene targeting in mice. Science 269:1427-1429.
179. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA and Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell 96:329-339.
180. Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M and Nakamura M (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA 95:15659-15664.
181. Kyrkouli SE, Stanley BG and Leibowitz SF (1987) Bombesin-induced anorexia: Sites of action in the rat brain. Peptides 8:237-241.
182. Kyrkouli SE, Stanley BG, Seirafi RD and Leibowitz SF (1990a) Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11:995-1001.
183. Kyrkouli SE, Stanley BG, Hutchinson R, Seirafi RD and Leibowitz SF (1990b) Peptide-amine interactions in the hypothalamic paraventricular nucleus: Analysis of galanin and neuropeptide Y in relation to feeding. Brain Res 521:185-191.
184. Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R and McIntyre KW (1997) Absence of IL-1 signaling and reduced inflammatory response in IL-1 type receptor-deficient mice. J Immunol 159:2452-2461.
185. Ladenheim EE, Taylor JE, Coy DH, Carrigan TS, Wohn A and Moran TH (1997) Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. Am J Physiol 272:R433-R437.
186. Lambert PD, Wilding JP, al-Dokhayel AA, Bohuon C, Comoy E, Gilbey SG and Bloom SR (1993a) A role for neuropeptide-Y, dynorphin, and noradrenalin in the central control of food intake after food-deprivation. Endocrinology 133:29-32.
187. Lambert PD, Wilding JP, al-Dokhayel AA, Gilbey SG and Bloom SR (1993b) The effect of central blockade of κ-opioid receptors on neuropeptide Y-induced feeding in the rat. Brain Res 629:146-148.
188. Lambert PD, Wilding JP, al-Dokhayel AA, Gilbey SG, Ghatei MA and Bloom SR (1994) Nalaxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: Evidence for neuropeptide Y-opioid interactions in the control of food uptake. Peptides 15:657-660.
189. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y and Kuhar MJ (1998) CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29:293-298.
190. Lamghans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinbor M and Kopin AS (1997) Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 112:280-286.
191. Larsen PJ, Tang-Christensen M, Holst JJ and Orskov C (1997) Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brain stem. Neuroscience 77:257-270.
192. Légradi G, Emerson CH, Ahima RS, Flier JS and Lechan RM (1997) Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138:2569-2576.
193. Leibel RL, Chung WK and Chua SC (1997) The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937-31940.
194. Leibowitz SF and Rossakis C (1979) Pharmacological characterization of perifornical hypothalamic dopamine receptors mediating feeding inhibition in the rat. Brain Res 172:115-130.
195. Leibowitz SF (1989) Hypothalamic neuropeptide Y, galanin, and amines: Concepts of coexistence in relation to feeding behavior. Ann NY Acad Sci 575:221-233.
196. 2 receptor effects on natural meal patterns. Peptides 12:1251-1260.
197. Leibowitz SF (1992) Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 15:491-497.
198. Leibowitz SF (1995) Brain peptides and obesity: Pharmacologic treatment. Obes Res 3(Suppl 4):573S-589S.
199. Leibowitz SF, Akabayashi A and Wang J (1998) Obesity on a high-fat diet: Role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci 18:2709-2719.
200. Leon LR, Kozak W, Peschon J and Kluger MJ (1997) Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am J Physiol 272:R563-R569.
201. Levi A, Eldridge JD and Paterson BM (1985) Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229:393-395.
202. Levin BE and Dunn-Meynell AA (1997) Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats. Am J Physiol 272:R1365-R1370.
203. Levin BE (1999) Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. Am J Physiol 276:R382-R387.
204. Levine AS, Rogers B, Kneip J, Grace M and Morley JE (1983) Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22:337-339.
205. Levine AS and Billington CJ (1989) Opioids: Are they regulators of feeding? Ann NY Acad Sci 575: 209-219.
206. Levine AS and Billington CJ (1997) Why do we eat? A neural systems approach. Annu Rev Nutr 17:597-619.
207. Levine AS and Billington CJ (1998) Obesity: Progress through genetic manipulation. Curr Biol 8:R251-R252.
208. Licinio J and Wong M-L (1997) Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 100:2941-2947.
209. 2-adrenergic receptor subtypes b and c. Science 273:803-805.
210. 3-adrenoceptors. Br J Clin Pharmacol 42:291-300.
211. Liu S, Croniger C, Arizmendi C, Harada-Shiba M, Ren J, Poli V, Hanson RW and Friedman JE (1999) Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPβ gene. J Clin Invest 103:207-213.
212. 1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats. Proc R Soc London B Biol Sci 263:881-886.
213. Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL and Clineschmidt BV (1987) In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 241:103-109.
214. Lotti VJ and Chang RSL (1989) A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol 162:273-280.
215. Lovejoy DA, Aubry JM, Turnbull A, Sutton S, Potter E, Yehling J, Rivier C and Vale WW (1998) Ectopic expression of the CRF-binding protein: Minor impact on HPA axis regulation but induction of sexually dimorphic weight gain. J Neuroendocrinol 10:483-491.
216. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP and Flier JS (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-742.
217. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO and Cone RD (1994) Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 371:799-802.
218. Lubkin M and Stricker-Krongrad A (1998) Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253:241-245.
219. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS and Rothwell NJ (1999) Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci USA 96:7047-7052.
220. Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Östlund P, Engfors C, Alheim K, Bartfai T, Iverfeldt K and Schultzberg M (1999) Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol 276:R644-R651.
221. 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18:211-219.
222. 2A-adrenergic receptor subtype. Science 273:801-803.
223. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA and Friedman JM (1995) Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161.
224. Mansour A, Fox CA, Akil H and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29.
225. Mantzoros CS, Frederich RC, Qu D, Lowell BB, Maratos-Flier E and Flier JS (1998) Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations. Diabetes 47:230-238.
226. 5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718-721.
227. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fischer SL, Burn P and Palmiter RD (1999) Response of melanocortin-4 receptor deficient mice to anorectic and orexigenic peptides. Nat Genet 21:119-122,
228. 2 receptors. Am J Physiol 274:G965-G970.
229. Matson CA and Ritter RC (1999) Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight. Am J Physiol 276:R1038-R1045.
230. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP and Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383:819-823.
231. McLaughlin CL and Baile CA (1981) Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide. Physiol Behav 26:433-437.
232. Meeran K, O'Shea D, Edwards CMB, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA and Bloom SR (1999) Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140:244-250.
233. Melnyk A and Himms-Hagen J (1998) Temperature-dependent feeding: Lack of role for leptin and defect in brown adipose tissue-ablated obese mice. Am J Physiol 274:R1131-R1135.
234. Menzaghi F, Heinrichs SC, Pich EM, Tilders FJH and Koob GF (1993) Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Res 618:76-82.
235. Merali Z, Moody TW and Coy D (1993) Blockade of brain bombesin/GRP receptors increases food intake in satiated rats. Am J Physiol 264:R1031-R1034.
236. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT and Trayhurn P (1996) Localization of leptin receptor mRNA and the long form splice variant (Ob/Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387:113-116.
237. Michalkiewicz T, Keith RL and Michalkiwicz M (1999) Enhanced cardiovascular responses in transgenic rats overexpressing neuropeptide Y. Abstracts of the 5th International NPY Meeting, Grand Cayman, p 35.
238. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T and Westfall T (1998) International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150.
239. Miller LJ, Holicky EL, Ulrich CD and Wieben ED (1995) Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109:1375-1380.
240. Millet L, Vidal H, Andreelli F, Larrouy D, Riou JP, Ricquier D, Laville M and Langin D (1997) Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 100:2665-2670.
241. Miltenberger RJ, Mynatt RL, Wilkinson JE and Woychik RP (1997) The role of the agouti gene in the yellow obese syndrome. J Nutr 127:1902S-1907S.
242. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA and Mobbs CV (1998) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294-297.
243. Moller DE (1994) Transgenic approaches to the pathogenesis of NIDDM. Diabetes 43:1394-1401.
244. Moran TH, Ameglio PJ, Schwartz GJ and McHugh PR (1992) Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46-R50.
245. Moran TH, Ameglio PJ, Peyton HJ, Schwartz GJ and McHugh PR (1993) Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 265:R620-R624.
246. Moran TH, Katz LF, Plata-Salaman CR and Schwartz GJ (1998) Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274:R618-R625.
247. Morley JE, Levine AS and Kneip J (1981) Muscimol induced feeding: A model to study the hypothalamic regulation of appetite. Life Sci 29:1213-1218.
248. Morley JE (1987) Neuropeptide regulation of appetite and weight. Endocr Rev 8:256-287.
249. Mueckler M (1994) Facilitative glucose transporters. Eur J Biochem 219:713-725.
250. Muglia L, Jacobson L, Dikkes P and Majzoub JA (1995) Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432.
251. Muglia LJ, Jacobson L, Weninger SC, Luedke CE, Bae DS, Jeong KH and Majzoub JA (1997) Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest 99:2923-2929.
252. Mynatt RL, Miltenberger RJ, Klebig ML, Zemel MB, Wilkinson JE, Wilkinson WO and Woychik RP (1997) Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc Natl Acad Sci USA 94:919-922.
253. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K, Matsui T and Noda T (1996) G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci USA 93:11825-11830.
254. Nagle DL, McGrail SH, Vitale J, Woolf EA, Dussault Jr BJ, DiRocco L, Holmgren L, Montagno J, Bork P, Huszar D, Fairchild-Huntress V, Ge P, Keilty J, Ebeling C, Baldini L, Gilchrist J, Burn P, Carlson GA and Moore KJ (1999) The mahogany protein is a receptor involved in suppression of obesity. Nature 398:148-152.
255. Nahon JL (1994) The melanin-concentrating hormone: From the peptide to the gene. Crit Rev Neurobiol 8:221-262.
256. 2C receptor gene. Nat Med 4:1152-1156.
257. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Okada H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y and Nakao K (1999) Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829.
258. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikuyama S, Wada E and Wada K (1997) Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390:165-169.
259. Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K, Yamada K and Wada K (1999) Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor. J Neurosci 19:948-954.
260. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T and Wakabayashi I (1996) Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137:5155-5158.
261. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I and Barsh GS (1997) Antagonism of central melanocortin receptors in in vitro and in vivo by agouti-related protein. Science 278:135-138.
262. Olson EN, Arnold HH, Rigby PW and Wold BJ (1996) Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1-4.
263. Owens MJ and Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473.
264. Palmiter RD, Erickson JC, Hollopeter G, Baraban SC and Schwartz MW (1998) Life without neuropeptide Y. Recent Prog Horm Res 53:163-199.
265. Parada MA, Hernandez L and Hoebel BG (1988) Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol Biochem Behav 30:917-923.
266. 2 receptor. Abstracts of the 5th International NPY Meeting, Grand Cayman, p 24.
267. 1 receptor. Nat Med 4:722-726.
268. Pépin MC, Pothier F and Barden N (1992) Impaired type glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature 355:725-728.
269. Plamondon H and Merali Z (1994) Push-pull perfusion reveals meal-dependent changes in the release of bombesin-like peptides in the rat paraventricular nucleus. Brain Res 668:54-61.
270. Plamondon H and Merali Z (1997) Anorectic action of bombesin requires receptor for corticotropin-releasing factor but not for oxytocin. Eur J Pharmacol 340:99-109.
271. Plata-Salaman CR (1991) Immunoregulators in the nervous system. Neurosci Biobehav Rev 15:185-215.
272. Plata-Salaman CR (1996) Anorexia during acute and chronic disease. Nutrition 12:67-78.
273. 1 receptor deficient mice. Abstracts of the 5th international NPY Meeting, Grand Cayman, p 42.
274. Presse F, Sorokovsky I, Max JP, Nicolaidis S and Nahon JL (1996) Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience 71:735-745.
275. Pu S, Dube MG, Edwards TG, Kalra SP and Kalra PS (1999a) Disruption of neural signaling within the hypothalamic ventromedial nucleus upregulates galanin gene expression in association with hyperphagia: An in situ analysis. Mol Brain Res 64:85-91.
276. Pu S, Jain MR, Horvath TL, Diano S, Kalra PS and Kalra SP (1999b) Interactions between neuropeptide Y and γ-aminobutyric acid in stimulation of feeding: A morphological and pharmacological analysis. Endocrinology 140:933-940.
277. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek J, Kanarek R and Maratos-Flier E (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247.
278. Rajewsky K, Gu H, Kühn R, Betz UAK, Müller W, Roes J and Schwenk F (1996) Conditional gene targeting. J Clin Invest 98:600-603.
279. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
280. Ren JM, Li PM, Zhang WR, Sweet LJ, Cline G, Shulman GI, Livingston JN and Goldstein BJ (1998) Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47:493-497.
281. 3-adrenoceptor in the regulation of body composition. J Clin Invest 100:1098-1106.
282. Richard D, Chapdelaine S, Deshaies Y, Pépin MC and Barden N (1993) Energy balance and lipid metabolism in transgenic mice bearing an antisense GCR gene construct. Am J Physiol 265:R146-R150.
283. Rohner-Jeanrenaud F (1995) A neuroendocrine reappraisal of the dual-centre hypothesis: Its implications for obesity and insulin resistance. Int J Obes Relat Metab Disord 19:517-534.
284. Rohrer DK and Kobilka BK (1998) G protein-coupled receptors: Functional and mechanistic insights through altered gene expression. Physiol Rev 78:35-52.
285. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA and Bloom SR (1997) Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138:351-355.
286. Rubinstein M, Mogil JS, Japon M, Chan EC, Allen RG and Low MJ (1996) Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis. Proc Natl Acad Sci USA 93:3995-4000.
287. Sahu A, Sninsky CA, Kalra PS and Kalra SP (1990) Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198.
288. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS and Kalra SP (1992) Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131:2979-2985.
289. Sahu A and Kalra SP (1993) Neuropeptidergic regulation of feeding behavior, neuropeptide Y. Trends Endocrinol Metab 4:217-224.
290. Sahu A, Sninsky CA and Kalra SP (1997) Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res 755:339-342.
291. Sahu A (1998) Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 139:795-798.
292. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ and Yanagisawa M (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
293. Samanin R and Garattini S (1996) Pharmacology of ingestive behavior. Thérapie 51:107-115.
294. Sanacora G, Kershaw M, Finkelstein JA and White JD (1990) Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730-737.
295. 1B receptor. Science 265:1875-1878.
296. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ, Flier JS, Lowell BB, Fraker DL and Alexander HR (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 185:171-175.
297. Sawchenko PE (1998) Toward a new neurobiology of energy balance, appetite, and obesity: The neuroanatomists weigh in. J Comp Neurol 402:435-441.
298. Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L and Hendriks WJ (1997) Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev Biol 188:134-146.
299. 5 receptor antisense oligodeoxynucleotides. Diabetes 46:1792-1798.
300. Schick RR, Yaksh TL and Go VLW (1986) An intragastric meal releases the putative satiety factor cholecystokinin from hypothalamic neurons in cats. Brain Res 370:349-353.
301. Schick RR, Reilly WM, Roddy DR, Yaksh TL and Go VLW (1987) Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain Res 418:20-26.
302. Schick RR, Samsami S, Zimmermann JP, Eberl T, Endres C, Schusdziarra V and Classen M (1993) Effect of galanin on food intake in rats: Involvement of lateral and ventromedial hypothalamic sites. Am J Physiol 264:R355-R361.
303. Schick RR, Schusdziarra V, Yaksh TL and Go VLW (1994) Brain regions where cholecystokinin exerts its effect on satiety. Ann NY Acad Sci 713:242-254.
304. Schwartz DH, Dorfman DB, Hernandez L and Hoebel BG (1988) Cholecystokinin: 1. Cck antagonists in the PVN induce feeding, 2. Effects of CCK in the nucleus accumbens on extracellular dopamine turnover, in Cholecystokinin Antagonists (Wang RV and Shoenfeld R eds) pp 285-305, Alan R. Liss, New York.
305. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC and Porte D Jr (1992) Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 13: 387-414.
306. Schwartz MW, Dallman MF and Woods SC (1995) Hypothalamic response to starvation: implications for the study of wasting disorders. Am J Physiol 269:R949-R957.
307. Schwartz MW, Seeley RJ, Campfield LA, Burn P and Baskin DG (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106.
308. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield A, Burn P and Baskin DG (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123.
309. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL and Drucker DJ (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258.
310. Scrocchi LA and Drucker DJ (1998) Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/-mice. Endocrinology 139:3127-3132.
311. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F and Kahn BB (1993) Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243-22246.
312. Shimazu T, Noma M and Saito M (1986) Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Brain Res 369:215-223.
313. Shimada M, Tritos NA, Lowell BB, Flier JS and Maratos-Flier E (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396:670-674.
314. Shimizu I, Hirota C, Ohboshi C and Shima K (1987) Identification and localization of glucagon-like peptide 1 and its receptor in rat brain. Endocrinology 121:1076-1082.
315. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL and Brown MS (1997) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-Ic in adipose tissue: Model for congenital generalized lipodystophy. Genes Dev 12:3182-3194.
316. Shimomura I, Hammer RE, Ikemoto S, Brown MS and Goldstein JL (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76.
317. Shughrue PJ, Lane MV and Merchenthaler I (1996) Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137:5159-5162.
318. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R and Stark KL (1997) Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 11:593-602.
319. Simansky KJ (1996) Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37-42.
320. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, LeMeur M, Roques BP, Maldonado R and Kieffer BL (1998) Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17:886-897.
321. Skuladottir GV, Jonsson L, Skarphedinsson JO, Mutulis F, Muceniece H, Raine A, Mutule I, Helgason J, Prusis P, Wikberg JE and Schioth HB (1999) Long-term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 126:27-34.
322. 2 receptors in corticotropin-releasing factor-and urocortin-induced anorexia. NeuroReport 9:1601-1606.
323. Smith BK, York DA and Bray GA (1994) Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides 15:1267-1272.
324. Smith BK, York DA and Bray GA (1998) Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol Biochem Behav 60:105-114.
325. Smith GP and Gibbs J (1994) Satiating effect of cholecystokinin. Ann NY Acad Sci 713:236-241.
326. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W and Lee KF (1998) Corticotropin releasing factor 1-defficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102.
327. Sneiderman AD, Cianflone K, Summers L, Fielding B and Frayn K (1997) The acylation-stimulating protein pathway and regulation of postprandial metabolism. Proc Nutr Soc 56:703-712.
328. Snyder SE and Salton SR (1998) Expression of VGF mRNA in the adult rat central nervous system. J Comp Neurol 394:91-105.
329. 1-adrenergic receptor in adipose tissue are resistant to obesity. Mol Endocrinol 11:27-38.
330. Son JH and Job TH (1997) Genetically engineered neural transmission. Mol Psychiatry 2:26-31.
331. Sonti G, Ilyin SE and Plata-Salaman CR (1996a) Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 270:R1394-R1402.
332. Sonti G, Ilyin SE and Plata-Salaman CR (1996b) Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides 17:517-520.
333. Spiegelman BM and Flier JS (1996) Adipogenesis and obesity: Rounding out the big picture. Cell 87:377-389.
334. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W and Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564.
335. Spindel E (1986) Mammalian bombesin-like peptides. Trends Neurosci 9:130-133.
336. Stanley BG, Hoebel BG and Leibowitz SF (1983) Neurotensin: Effects of hypothalamic and intravenous injections on eating and drinking in rats. Peptides 4:493-500.
337. Stanley BG, Kyrkouli SE, Lampert S and Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189-1192.
338. Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance, in The Biology of Neuropeptide Y and Related Peptides (Colmers WF and Wahlestedt C eds) pp 457-509, Humana Press, Totowa.
339. Stellar E (1954) The physiology of motivation. Reprinted in 1994 Psychol Rev 101:301-311.
340. Sternberg EM (1997) Neural-immune interactions in health and disease. J Clin Invest 100:2641-2647.
341. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE and Vale W (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130:3378-3386.
342. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF and Vale WW (1994) Overproduction of corticotropin-releasing factor in transgenic mice: A Genetic model of anxiogenic behavior. J Neurosci 14:2579-2584.
343. Strader CD, Hwa JJ, Van Heek M and Parker EM (1998) Novel molecular targets for the treatment of obesity. Drug Discovery Today 3:250-256.
344. Stratford TR and Kelley AE (1997) GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J Neurosci 17:4434-4440.
345. Stricker-Krongrad A, Beck B and Burlet C (1996) Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. Eur J Pharmacol 295:27-34.
346. Sun YS, Brunicardi FC, Druck P, Walfisch S, Berlin SA, Chance RE, Gingerich RL, Elahi D and Andersen DK (1985) Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 151:130-140.
347. 3-adrenergic receptor gene. J Biol Chem 270:29483-29492.
348. Swanson LW and Sawchenko PE (1983) Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269-324.
349. Sweet DC, Levine AS, Billington CJ and Kotz CM (1999) Feeding response to central orexins. Brain Res 821:535-538.
350. Taché Y and Brown M (1982) On the role of bombesin in homeostasis. Trends Neurosci 5:431-433.
351. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N and Kishimoto T (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-361.
352. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M and Sheikh SP (1996) Central administration of GLP-1 (7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848-R856.
353. Tatemoto K (1982) Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485-5489.
354. Taylor IL and Garcia R (1985) Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice. Am J Physiol 248:G277-G280.
355. Taylor IL (1989) Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y and peptide YY, in Handbook of Physiology, Section 6, Volume 2 (Rauner BB, Makhlouf GM and Schultz SG ed) pp 475-543, American Physiological Society, Bethesda.
356. 2C serotonin receptors. Nature 374:542-546.
357. Tempel DL and Leibowitz SF (1994) Adrenal steroid receptors: interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J Neuroendocrinol 6:479-501.
358. Thibault L and Booth DA (1999) Macronutrient-specific dietary selection in rodents and its neural bases. Neurosci Biobehav Rev 23:457-528.
359. Thiele TE, Marsh DJ, Ste-Marie L, Bernstein IL and Palmiter RD (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396:366-369.
360. Thomas SA and Palmiter RD (1997) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387:94-97.
361. 1A receptor. Proc Natl Acad Sci USA 88:7491-7495.
362. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F and Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162-166.
363. Tritos NA, Vincent D, Gillette J, Ludwig DS, Flier ES and Maratos-Flier E (1998a) Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus. Diabetes 47:1687-1692.
364. Tritos NA, Elmquist JK, Mastaitis JW, Flier JS and Maratos-Flier E (1998b) Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice. Endocrinology 139:4634-4641.
365. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER and Tonegawa S (1996a) Subregion-and cell type-restricted gene knockout in mouse brain. Cell 87:1315-1326.
366. Tsien JZ, Huerta PT and Tonegawa S (1996b) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338.
367. Tsujii S and Bray GA (1991) GABA-related feeding control in genetically obese rats. Brain Res 540:48-54.
368. Turnbull AV and Rivier C (1997) Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 215:1-10.
369. Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF and Rivier C (1999) CRF type 1 receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140:1013-1017.
370. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J and Bloom SR (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72.
371. Turton MD, O'Shea D and Bloom SR (1997) Central effects of neuropeptide Y with emphasis on its role in obesity and diabetes, in Neuropeptide Y and Drug Development (Grundemar L and Bloom SR eds) pp 15-39, Academic Press, San Diego.
372. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park S-H, Ram PA, Waxman DJ and Davey HW (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244.
373. Uehara A, Sekiya C, Takasugi Y, Namiki M and Arimura A (1989) Anorexia induced by interleukin 1: Involvement of corticotropin-releasing factor. Am J Physiol 257:R613-H617.
374. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M, Fujimiya M, Nakajima Y, Ohmoto Y, Ohnaka M, Nakaya Y, Miyazaki J and Kasuga M (1999) Decreased food intake and body weight in pancreatic polypeptide overexpressing mice. Gastroenterology 117:1427-1432.
375. Uysal KT, Wiesbrock SM, Marino MW and Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614.
376. Vaccarino FJ, Bloom FE, Rivier J, Vale W and Koob GF (1985) Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature 314:167-168.
377. Vale W, Speiss J, Rivier C and Rivier J (1981) Characterization of a 41-amino acid residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397.
378. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD and Davis HR Jr (1997) Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99:385-390.
379. Vanhoutte PM, Saxena PR, Paoletti R, Brunello N, Jackson N and Jackson AS (1993) Serotonin: From Cell Biology to Pharmacology and Therapeutics, Kluwer Academic, Dordrecht.
380. Vaughan JM, Fischer WH, Hoeger C, Rivier J and Vale W (1989) Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125:1660-1665.
381. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin and to corticotropin-releasing factor. Nature 378:287-292.
382. Ventre J, Doebber T, Wu M, MacNaul K, Stephens K, Pasparakis M, Kollias G and Moller DE (1997) Targeted disruption of the tumor necrosis factor-α gene. Metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531.
383. von Schrenck T, Wang L-H, Coy DH, Villanueva ML, Mantey S and Jensen RT (1990) Potent bombesin receptor antagonists distinguish receptor subtypes. Am J Physiol 259:G468-G473.
384. Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R and Battey J (1991) cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 6:421-430.
385. Wada E, Wray S, Key S and Battey J (1992) Comparison of gene expression for two distinct bombesin receptor subtypes in postnatal rat central nervous system. Mol Cell Neurosci 3:446-460.
386. Wada E, Watase K, Yamada K, Ogura H, Yamano M, Inomata Y, Eguchi J, Yamamoto K, Sunday ME, Maeno H, Mikoshiba K, Ohki-Hamazaki H and Wada K (1997) Generation and characterization of mice lacking gastrin-releasing peptide receptor. Biochem Biophys Res Commun 239:28-33.
387. 1 receptor antagonist BIBO3304 and its effect on feeding in rodents. Br J Pharmacol 125:549-555.
388. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA and Bloom SR (1993) Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and deceased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132:1939-1944.
389. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, Gill JS, Burrin JM, Polak JM and Bloom SR (1988) Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37:763-772.
390. Williams G, Gill JS, Lee YC, Cardoso HM, Okpere BE and Bloom SR (1989) Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 38:321-327.
391. Wilson BD, Ollmann MM and Barsh GS (1999) The role of Agouti-related protein (Agrp) in regulation of body weight. Mol Med Today 5:250-256.
392. Winzell MS, Lowe ME and Erlanson-Albertsson C (1998) Rat gastric procolipase: Sequence, expression, and secretion during high-fat feeding. Gastroenterology 115:1179-1185.
393. Woods SC, Seeley RJ, Porte D Jr and Schwartz MW (1998) Signals that regulate food intake and energy homeostasis, Science 280:1378-1383.
394. Wright DE, Seroogy KB, Lundgren KH, Davis BM and Jennes L (1995) Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351:357-373.
395. Wurtman RJ and Wurtman JJ (1995) Brain serotonin, carbohydrate craving, obesity and depression. Obes Res 3:477S-480S.
396. Wynick D, Small CJ, Bacon A, Holmes FE, Norman M, Ormandy CJ, Kilic E, Kerr NCH, Ghatei M, Talamantes F, Bloom SR and Pachnis V (1998) Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci USA 95:12671-12676.
397. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM and Tonegawa S (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
398. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T, Hashimoto K, Satoh T, Wakabayashi K, Taketo MM and Mori M (1997) Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94:10862-10867
399. Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, Serino R, Nomura M, Shibuya I, Matsukura S and Yamashita H (1999) Down regulation of the prepro-orexin gene expression in genetically obese mice. Mol Brain Res 65:14-22.
400. Yang Y-K, Thompson DA, Dickinson CJ, Wilken J, Barsh GS, Kent SBH and Gantz I (1999) Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol 13:148-155.
401. Yaswen L, Diehl N, Brennan MD and Hochgeschwender U (1999) Obesity in the mouse model of opiomelanocortin deficiency respond to peripheral melanocortin. Nat Med 5:1066-1070.
402. York DA and Hansen B (1998) Animal models of obesity, in Handbook of Obesity (Bray GA, Bouchard C and James WPT) pp 191-221, Dekker, New York.
403. York DA and Lin L (1996) Enterostatin: A peptide regulator of fat ingestion, in Molecular and Genetic Aspects of Obesity (Bray GA and Ryan DH ed) pp 281-297, Louisiana State University, Baton Rouge.
404. Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M and Sakata T (1999) Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48:2286-2291.
405. Zadina JE, Hackler L, Ge L-J and Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386:499-502.
406. Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B and Rohner-Jeanrenaud F (1999) Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 48:365-370.
407. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F and Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758.
408. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.
409. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A, Kostura MJ, Stevens K, Rosen H, Norht RJ, Chen HY, Tocci MJ, Kluger MJ and Van der Ploeg LHT (1995) Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3:9-19.
410. Zhou Q-Y and Palmiter RD (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.